Metagenomics In Healthcare Market Intelligence Report Covers Trends, Segments And Regional Growth

The metagenomics sector within healthcare is on the brink of substantial growth, driven by advancements in technology and evolving medical needs. As this field gains traction, it is poised to reshape diagnostics and personalized treatment approaches through detailed microbial analysis. Here is an in-depth look at the market size, influential factors, prominent companies, emerging trends, and segmentation within this rapidly expanding industry.

Forecasted Market Size and Growth Outlook for Metagenomics in Healthcare
The metagenomics in healthcare market is projected to grow significantly, reaching a value of $5.46 billion by 2030. This reflects an impressive compound annual growth rate (CAGR) of 17.5%. Several key factors contribute to this expected surge, such as the rising use of precision infectious disease diagnostics, increasing investments in microbiome-based therapeutics, expansion of genomic epidemiology projects, the growing role of artificial intelligence in microbial data analysis, and a heightened focus on personalized treatment strategies. Additionally, trends like wider adoption of metagenomic diagnostics in clinical environments, increased use of microbiome profiling for disease, integration of next-generation sequencing (NGS) in infection control, and intensified research in personalized microbial therapies are shaping the market's future.

The metagenomics in healthcare market size has grown rapidly in recent years. It will grow from $2.44 billion in 2025 to $2.87 billion in 2026 at a compound annual growth rate (CAGR) of 17.8%. The growth in the historic period can be attributed to advancements in sequencing technologies, increased incidence of infectious diseases, expansion of microbiome research programs, rising demand for culture-independent diagnostics, availability of clinical-grade sequencing workflows.

Download a free sample of the metagenomics in healthcare market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28267&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Key Players Leading the Metagenomics in Healthcare Market
The competitive landscape features a diverse range of companies specializing in metagenomics applications within healthcare. Notable market participants include F. Hoffmann-La Roche AG, Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., BGI Genomics Co. Ltd., Novogene Corporation, Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., MedGenome Labs Limited, Zymo Research Corporation, BaseClear B.V., Psomagen Inc., Karius Inc., Microsynth AG, Macrogen Inc., Norgen Biotek Corp., Tiny Health Inc., CosmosID Inc., Kanvas Biosciences Inc., Phase Genomics Inc., and Wobble Genomics Inc. In a recent development, Mapmygenome India Limited, a genomics and diagnostics company from India, acquired Canada-based Microbiome Insights Inc. in May 2025. This acquisition is set to expand Mapmygenome's microbiome sequencing and analysis capabilities, enhance its footprint in North America, and bolster its offerings in personalized health, genomics, and research services.

Innovations and Trends Accelerating Growth in Metagenomics
Industry leaders are increasingly focused on pioneering microbial community profiling technologies to improve disease diagnostics and foster personalized treatments. Microbial community profiling involves an in-depth analysis of microbial populations within samples, identifying their diversity, composition, and functional roles through sequencing and advanced bioinformatics tools. For example, in August 2024, MGI Tech Co. Ltd., a biotechnology firm based in China, introduced a Human Microbiome Metagenomics Sequencing Package designed to push forward microbial research and healthcare applications. This solution provides a fully automated, end-to-end workflow for analyzing human microbiome diversity, functions, and disease associations. It streamlines processes by minimizing manual effort, enhancing reproducibility, and cutting costs, thereby making large-scale and clinical microbiome studies more feasible. Researchers benefit from rapid, accurate microbial identification and scalable throughput, aiding biomarker discovery and advancing translational health research.

View the full metagenomics in healthcare market report:
https://www.thebusinessresearchcompany.com/report/metagenomics-in-healthcare-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

How the Metagenomics in Healthcare Market is Organized
The market is segmented into multiple categories based on distinct criteria:
1) Types - including Sample Extraction Kits and Metagenomics Kits
2) Technology - covering Next-Generation Sequencing, Polymerase Chain Reaction, and Microarray
3) Workflow - comprising Sample Collection, DNA Extraction, Library Preparation, and Sequencing
4) Application - such as Infectious Disease Diagnosis, Genomic Epidemiology, Personalized Medicine, Microbiome Analysis, and Drug Discovery
5) End User - including Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, and Biotechnology Companies.

Further breakdowns under these segments include:
- Sample Extraction Kits: DNA Extraction Kits, RNA Extraction Kits, and Protein Extraction Kits
- Metagenomics Kits: Library Preparation Kits, Sequencing Kits, and Target Enrichment Kits.

This detailed segmentation offers a comprehensive understanding of the components and applications driving the market expansion in metagenomics within healthcare.

Our 2026 market reports now include enhanced strategic insights through:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.